AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle

Gene Therapy

Volumn 12, Issue 17, 2005, Pages 1347-1352

  Lie A Ling, M ^a   Bakker, C T ^a   Wesseling, J G ^a   Bosma, P J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adenovirus; Cloning system; Late expressions; Tropism

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; GLYCOPROTEIN E1; GREEN FLUORESCENT PROTEIN;

ARTICLE; CANCER THERAPY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; LIFE CYCLE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN TARGETING; RESTRICTION SITE; THERAPY EFFECT; TRANSGENE; VALIDATION PROCESS; VIROGENESIS; VIRUS FIBER; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADENOVIRUS E1 PROTEINS; ADENOVIRUS E3 PROTEINS; CAPSID PROTEINS; CLONING, MOLECULAR; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; NEOPLASMS; OLIGOPEPTIDES; TRANSGENES; TROPISM; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 30644470587     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302546     Document Type: Article

References (30)

1. Fechner H et al. A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication. Gene Therapy 2003; 10: 1680-1690.
2. Post DE, Khuri FR, Simons JW, Van Meir EG. Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003; 14: 933-946.
3. Savontaus MJ, Sauter BV, Huang TG, Woo SL. Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells. Gene Therapy 2002; 9: 972-979.
4. van Beusechem VW et al. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Therapy 2003; 10: 1982-1991.
5. Dmitriev I et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72: 9706-9713.
6. Miller CR et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998; 58: 5738-5748.
7. Li Y et al. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy Cancer Res 1999; 59: 325-330.
8. Doronin K et al. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein. J Virol 2000; 74: 6147-6155.
9. Tollefson AE et al. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: Characterization of cells infected with adp mutants. Virology 1996; 220: 152-162.
10. Ahmed A et al. Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy. Gene Therapy 2003; 10: 1663-1671.
11. Li H et al. Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles. Hum Gene Ther 2001; 12: 2155-2165.
12. Bernt KM et al. Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors. Cancer Res 2002; 62: 6089-6098.
13. Hemminki A et al. Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential. Cancer Gene Ther 2003; 10: 583-588.
14. Chartier C et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810.
15. He TC et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
16. Mizuguchi H et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Therapy 2001; 8: 730-735.
17. Sauthoff H et al. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. Hum Gene Ther 2002; 13: 1859-1871.
18. Zeng M et al. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques 2001; 31: 260-262.
19. Fueyo J et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 2000; 19: 2-12.
20. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000; 81: 2573-2604.
21. Louis N, Evelegh C, Graham FL. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 1997; 233: 423-429.
22. Fallaux FJ et al. Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215-222.
23. Gao GP, Engdahl RK, Wilson JM. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. Hum Gene Ther 2000; 11: 213-219.
24. Shimizu Y et al. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992; 52: 252-260.
25. Wesseling JG et al. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Therapy 2001; 8: 969-976.
26. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166: 557-580.
27. Takahashi N, Yoshikura H, Kobayashi I. An Escherichia coli strain, BJ5183, that shows highly efficient conservative (two-progeny) DNA double-strand break repair of restriction breaks. Gene 2003; 303: 89-97.
28. Dull T et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
29. Bewig B, Schmidt WE. Accelerated titering of adenoviruses. Biotechniques 2000; 28: 870-873.
30. Sauthoff H, Heitner S, Rom WN, Hay JG. Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector. Hum Gene Therapy 2000; 11: 379-388.